TY - JOUR
T1 - Is Gray Matter Volume an Intermediate Phenotype for Schizophrenia? A Voxel-Based Morphometry Study of Patients with Schizophrenia and Their Healthy Siblings
AU - Honea, Robyn A.
AU - Meyer-Lindenberg, Andreas
AU - Hobbs, Katherine B.
AU - Pezawas, Lukas
AU - Mattay, Venkata S.
AU - Egan, Michael F.
AU - Verchinski, Beth
AU - Passingham, Richard E.
AU - Weinberger, Daniel R.
AU - Callicott, Joseph H.
N1 - Funding Information:
This work was supported by grants from the National Institute of Mental Health intramural program.
PY - 2008/3/1
Y1 - 2008/3/1
N2 - Background: Shared neuropathological characteristics of patients with schizophrenia and their siblings might represent intermediate phenotypes that could be used to investigate genetic susceptibility to the illness. We sought to discover previously unidentified gray matter volume differences in patients with schizophrenia and their siblings with optimized voxel-based morphometry. Methods: We studied 169 patients with schizophrenia, 213 of their unaffected siblings, and 212 healthy volunteers from the Clinical Brain Disorders Branch/National Institute of Mental Health Genetic Study of Schizophrenia with magnetic resonance imaging. Results: Patients with schizophrenia had significant regional gray matter decreases in the frontal, temporal, and parietal cortices compared with healthy volunteers. Their unaffected siblings tended to share gray matter decreases in the medial frontal, superior temporal, and insular cortices, but these decreases were not significant after correction for multiple comparisons, even when we looked at a subgroup of siblings with a past history of mood disorder. As an exploratory analysis, we estimated heritability with regions of interest from the VBM analysis as well as from the hippocampus. Hippocampal volume was significantly correlated within sibling-pairs. Conclusions: Our findings confirm and extend previous voxel-based morphometry analyses in ill subjects with schizophrenia. Furthermore, these data argue that although siblings might share some regional gray matter decreases with their affected siblings, the pattern of regional differences might be a weak intermediate phenotype for schizophrenia.
AB - Background: Shared neuropathological characteristics of patients with schizophrenia and their siblings might represent intermediate phenotypes that could be used to investigate genetic susceptibility to the illness. We sought to discover previously unidentified gray matter volume differences in patients with schizophrenia and their siblings with optimized voxel-based morphometry. Methods: We studied 169 patients with schizophrenia, 213 of their unaffected siblings, and 212 healthy volunteers from the Clinical Brain Disorders Branch/National Institute of Mental Health Genetic Study of Schizophrenia with magnetic resonance imaging. Results: Patients with schizophrenia had significant regional gray matter decreases in the frontal, temporal, and parietal cortices compared with healthy volunteers. Their unaffected siblings tended to share gray matter decreases in the medial frontal, superior temporal, and insular cortices, but these decreases were not significant after correction for multiple comparisons, even when we looked at a subgroup of siblings with a past history of mood disorder. As an exploratory analysis, we estimated heritability with regions of interest from the VBM analysis as well as from the hippocampus. Hippocampal volume was significantly correlated within sibling-pairs. Conclusions: Our findings confirm and extend previous voxel-based morphometry analyses in ill subjects with schizophrenia. Furthermore, these data argue that although siblings might share some regional gray matter decreases with their affected siblings, the pattern of regional differences might be a weak intermediate phenotype for schizophrenia.
KW - Brain
KW - MRI
KW - gray matter volume
KW - heritability
KW - hippocampus
KW - schizoaffective
KW - schizophrenia
KW - siblings
KW - voxel-based morphometry
UR - http://www.scopus.com/inward/record.url?scp=38949193560&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=38949193560&partnerID=8YFLogxK
U2 - 10.1016/j.biopsych.2007.05.027
DO - 10.1016/j.biopsych.2007.05.027
M3 - Article
C2 - 17689500
AN - SCOPUS:38949193560
SN - 0006-3223
VL - 63
SP - 465
EP - 474
JO - Biological Psychiatry
JF - Biological Psychiatry
IS - 5
ER -